Literature DB >> 11230652

Hypervascular hepatocellular carcinoma: detection with double arterial phase multi-detector row helical CT.

T Murakami1, T Kim, M Takamura, M Hori, S Takahashi, M P Federle, K Tsuda, K Osuga, S Kawata, H Nakamura, M Kudo.   

Abstract

PURPOSE: To assess whether double arterial phase imaging with multi-detector row helical computed tomography improves detection of hypervascular hepatocellular carcinoma (HCC).
MATERIALS AND METHODS: Fifty-one patients with 96 hypervascular HCCs underwent double arterial phase imaging of the entire liver. At measured delay after intravenous administration of 2 mL/kg of contrast medium at a rate of 5 mL/sec, the early and late arterial phase images were obtained serially during a single breath hold with interscan delay of 5.0 seconds. Detector row configuration of 2.5 x 4 mm, pitch of 6, and scanning time of 10.5 seconds for each phase were used. Forty 5-mm-thick reconstruction images were obtained for each phase. Each image set was interpreted separately by three observers, who were unaware of tumor burden in the liver, to detect hypervascular HCC. Sensitivity, positive predictive value, and area below the receiver operating characteristic curve (A(z)) for early and late arterial phases separately and together were calculated.
RESULTS: Mean sensitivity and positive predictive value for hypervascular HCC were 54% and 85% for the early arterial phase, 78% and 83% for the late arterial phase, and 86% and 92% for the double arterial phase, respectively. Double arterial phase imaging showed significantly superior sensitivity compared with early or late arterial phase imaging alone for detecting HCC (P <.05). The mean A(z) value for double arterial phase was significantly higher than that for early or late arterial phase imaging alone (P <.05). Double arterial phase imaging showed the lowest number of false-positive lesions.
CONCLUSION: Double arterial phase imaging is recommended to improve detection of hypervascular HCCs and reduce false-positive lesions.

Entities:  

Mesh:

Year:  2001        PMID: 11230652     DOI: 10.1148/radiology.218.3.r01mr39763

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  38 in total

1.  Comparison of two contrast materials with different iodine concentrations in enhancing the density of the the aorta, portal vein and liver at multi-detector row CT: a randomized study.

Authors:  Hiromasa Suzuki; Hidekazu Oshima; Norio Shiraki; Chisa Ikeya; Yuta Shibamoto
Journal:  Eur Radiol       Date:  2004-08-12       Impact factor: 5.315

Review 2.  MDCT of primary liver malignancies.

Authors:  Alfonso Marchianò
Journal:  Eur Radiol       Date:  2003-12       Impact factor: 5.315

3.  Contrast resolution in multidetector-row CT with 16 detector rows: phantom study.

Authors:  Kosuke Matsubara; Kichiro Koshida; Masayuki Suzuki; Norio Hayashi; Tadanori Takata; Hideo Tsujii; Tomoyuki Yamamoto; Osamu Matsui
Journal:  Radiol Phys Technol       Date:  2007-11-01

4.  Outcomes of follow-up CT for small (5-10-mm) arterially enhancing nodules in the liver and risk factors for developing hepatocellular carcinoma in a surveillance population.

Authors:  Min Jung Park; Young-Sun Kim; Won Jae Lee; Hyo K Lim; Hyunchul Rhim; Jongmee Lee
Journal:  Eur Radiol       Date:  2010-06-19       Impact factor: 5.315

5.  Optimizing scan timing of hepatic arterial phase by physiologic pharmacokinetic analysis in bolus-tracking technique by multi-detector row computed tomography.

Authors:  Isao Yamaguchi; Eiji Kidoya; Masayuki Suzuki; Hirohiko Kimura
Journal:  Radiol Phys Technol       Date:  2010-09-25

6.  Evaluation of a method for improving the detection of hepatocellular carcinoma.

Authors:  Edgar Bendik; Peter B Noël; Daniela Münzel; Alexander A Fingerle; Martin Henninger; Christian Markus; Alain Vlassenbroek; Ernst J Rummeny; Martin Dobritz
Journal:  Eur Radiol       Date:  2013-09-03       Impact factor: 5.315

7.  Current status of therapy for hepatocellular carcinoma.

Authors:  Kathleen E Corey; Daniel S Pratt
Journal:  Therap Adv Gastroenterol       Date:  2009-01       Impact factor: 4.409

8.  [Multidetector computed tomography of the liver].

Authors:  W Schima; C Kulinna; A Ba-Ssalamah; T Grünberger
Journal:  Radiologe       Date:  2005-01       Impact factor: 0.635

9.  Effect of contrast injection protocol with dose tailored to patient weight and fixed injection duration on aortic and hepatic enhancement at multidetector-row helical CT.

Authors:  Kazuo Awai; Shinichi Hori
Journal:  Eur Radiol       Date:  2003-05-08       Impact factor: 5.315

Review 10.  Imaging of liver cancer.

Authors:  Ben Ariff; Claire R Lloyd; Sameer Khan; Mohamed Shariff; Andrew V Thillainayagam; Devinder S Bansi; Shahid A Khan; Simon D Taylor-Robinson; Adrian K P Lim
Journal:  World J Gastroenterol       Date:  2009-03-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.